Jost Vielmetter

8.4k citations
31 papers · 2.0k indexed · 1 hit paper · h-index 20
Topics
Monoclonal and Polyclonal Antibodies Research (12 papers)Glycosylation and Glycoproteins Research (6 papers)Retinal Development and Disorders (5 papers)

In The Last Decade

Jost Vielmetter

31 papers receiving 1.9k citations

Hit Papers

Engineered antibody Fc variants with enhanced effector fu...20062026201220192006100200300400500

Peers

Jost Vielmetter
Comparison fields: 5 of 116
  • Molecular Biology 1.1k
  • Radiology, Nuclear Medicine and Imaging 626
  • Cellular and Molecular Neuroscience 521
  • Immunology 459
  • Oncology 224
Replace Kevin Ryder with:
Kevin Ryder United States
Randell T. Libby United States
Ivana Nikić Germany
Naohito Nozaki Japan
Chi‐Hon Lee United States
Terumi Kohwi-shigematsu United States
Davide Foletti United States
Andrew W. Stoker United Kingdom
Sabine Freundlieb Germany
Hirofumi Doi Japan
Jost Vielmetter relative to Kevin Ryder United States Kevin Ryder's profile →
Citations per field
00.5×10×15×17.8×
Kevin Ryder · 1×
Citations per year

Countries citing papers authored by Jost Vielmetter

Since Specialization
Citations

This map shows the geographic impact of Jost Vielmetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jost Vielmetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jost Vielmetter more than expected).

Fields of papers citing papers by Jost Vielmetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jost Vielmetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jost Vielmetter. The network helps show where Jost Vielmetter may publish in the future.

Co-authorship network of co-authors of Jost Vielmetter

This figure shows the co-authorship network connecting the top 25 collaborators of Jost Vielmetter. A scholar is included among the top collaborators of Jost Vielmetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jost Vielmetter. Jost Vielmetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 31
3 4
4 3
5 65
6 12
7 185
8 68
9 44
10 28
11 4
12 27
13
Engineered antibody Fc variants with enhanced effector functionbreakdown →
590
14 62
15 4
16 10
17 31
18 116
19 95
20 123

About Jost Vielmetter

Jost Vielmetter is a scholar working on Virology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 2.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Glycosylation and Glycoproteins Research (6 papers) and Retinal Development and Disorders (5 papers). The work is most often cited by research in Developmental Neuroscience (167 citations), Cellular and Molecular Neuroscience (521 citations) and Radiology, Nuclear Medicine and Imaging (626 citations). Jost Vielmetter has collaborated with scholars based in United States, Germany and Egypt. Frequent co-authors include Claudia A. O. Stuermer, Robert J. Hayes, Bassil I. Dahiyat, David F. Carmichael, William J. Dreyer, Sean C. Yoder, Omid Vafa, Greg A. Lazar, Sher Karki and Helen Chung. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026